Lu Gan
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
Papers in
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 19
-
- Nanoplatforms for cancer theranostics 11
- Co-authors
- Xiangliang Yang (57 shared papers)Tuying Yong (38 shared papers)Nana Bie (21 shared papers)Xiaoqiong Zhang (15 shared papers)Zhaohan Wei (22 shared papers)Guiting Zhan (9 shared papers)Abdul Hakeem (4 shared papers)Haiping He (13 shared papers)
- Journals
- ACS Applied Materials & Interfaces (7 papers)Theranostics (5 papers)Advanced Science (5 papers)Journal of Controlled Release (4 papers)Nature Communications (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Gan
173 papers receiving 7.5k citations
Lu Gan's Hit Papers
Peers
Comparison fields: 5 of 113
- Biomaterials 849
- Biomedical Engineering 965
- Molecular Biology 1.3k
- Molecular Medicine 128
- Cancer Research 249
Countries citing papers authored by Lu Gan
This map shows the geographic impact of Lu Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Gan more than expected).
Fields of papers citing papers by Lu Gan
This network shows the impact of papers produced by Lu Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Gan. The network helps show where Lu Gan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Gan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy Hit paper breakdown → | 2019 | 731 |
| 2 | 2018 | 328 | |
| 3 | Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles Hit paper breakdown → | 2021 | 296 |
| 4 | 2020 | 274 | |
| 5 | 2010 | 227 | |
| 6 | Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts Hit paper breakdown → | 2022 | 226 |
| 7 | 2019 | 202 | |
| 8 | 2020 | 183 | |
| 9 | 2001 | 165 | |
| 10 | 2011 | 158 | |
| 11 | 2021 | 132 | |
| 12 | 2016 | 125 | |
| 13 | 2017 | 125 | |
| 14 | 2015 | 118 | |
| 15 | 2018 | 108 | |
| 16 | 2022 | 108 | |
| 17 | 2021 | 107 | |
| 18 | 2015 | 101 | |
| 19 | 2020 | 98 | |
| 20 | 2017 | 94 |
About Lu Gan
Lu Gan is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Cancer Research and Oncology, having authored 185 papers that have together received 7.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (19 papers), Nanoplatforms for cancer theranostics (11 papers), Extracellular vesicles in disease (9 papers), Perovskite Materials and Applications (7 papers), Silicon Nanostructures and Photoluminescence (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), MicroRNA in disease regulation (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Biomaterials (849 citations), Biomedical Engineering (965 citations), Molecular Biology (1.3k citations), Molecular Medicine (128 citations) and Cancer Research (249 citations). Lu Gan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xiangliang Yang, Tuying Yong, Nana Bie, Xiaoqiong Zhang, Zhaohan Wei, Guiting Zhan, Abdul Hakeem, Haiping He, Zhizhen Ye and Jun Hu. Their work appears in journals such as ACS Applied Materials & Interfaces, Theranostics, Advanced Science, Journal of Controlled Release and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.